chr3-189869302-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003722.5(TP63):​c.1130-22A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 1,607,668 control chromosomes in the GnomAD database, including 50,107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9766 hom., cov: 32)
Exomes 𝑓: 0.23 ( 40341 hom. )

Consequence

TP63
NM_003722.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.14

Publications

13 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 3-189869302-A-G is Benign according to our data. Variant chr3-189869302-A-G is described in ClinVar as Benign. ClinVar VariationId is 259124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003722.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP63
NM_003722.5
MANE Select
c.1130-22A>G
intron
N/ANP_003713.3
TP63
NM_001114980.2
MANE Plus Clinical
c.848-22A>G
intron
N/ANP_001108452.1Q9H3D4-2
TP63
NM_001329964.2
c.1124-22A>G
intron
N/ANP_001316893.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP63
ENST00000264731.8
TSL:1 MANE Select
c.1130-22A>G
intron
N/AENSP00000264731.3Q9H3D4-1
TP63
ENST00000354600.10
TSL:1 MANE Plus Clinical
c.848-22A>G
intron
N/AENSP00000346614.5Q9H3D4-2
TP63
ENST00000440651.6
TSL:1
c.1118-22A>G
intron
N/AENSP00000394337.2Q9H3D4-11

Frequencies

GnomAD3 genomes
AF:
0.316
AC:
48059
AN:
151942
Hom.:
9745
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.583
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.262
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.190
Gnomad FIN
AF:
0.214
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.218
Gnomad OTH
AF:
0.318
GnomAD2 exomes
AF:
0.224
AC:
56225
AN:
250938
AF XY:
0.221
show subpopulations
Gnomad AFR exome
AF:
0.593
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.265
Gnomad EAS exome
AF:
0.156
Gnomad FIN exome
AF:
0.210
Gnomad NFE exome
AF:
0.219
Gnomad OTH exome
AF:
0.232
GnomAD4 exome
AF:
0.226
AC:
328802
AN:
1455606
Hom.:
40341
Cov.:
30
AF XY:
0.224
AC XY:
162432
AN XY:
724606
show subpopulations
African (AFR)
AF:
0.600
AC:
19996
AN:
33332
American (AMR)
AF:
0.146
AC:
6506
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
7021
AN:
26092
East Asian (EAS)
AF:
0.150
AC:
5945
AN:
39642
South Asian (SAS)
AF:
0.186
AC:
15983
AN:
86140
European-Finnish (FIN)
AF:
0.207
AC:
11067
AN:
53388
Middle Eastern (MID)
AF:
0.348
AC:
2005
AN:
5758
European-Non Finnish (NFE)
AF:
0.222
AC:
245443
AN:
1106394
Other (OTH)
AF:
0.247
AC:
14836
AN:
60160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
12280
24560
36840
49120
61400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8568
17136
25704
34272
42840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.316
AC:
48113
AN:
152062
Hom.:
9766
Cov.:
32
AF XY:
0.311
AC XY:
23098
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.583
AC:
24169
AN:
41470
American (AMR)
AF:
0.213
AC:
3261
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
908
AN:
3472
East Asian (EAS)
AF:
0.151
AC:
778
AN:
5168
South Asian (SAS)
AF:
0.191
AC:
918
AN:
4816
European-Finnish (FIN)
AF:
0.214
AC:
2263
AN:
10574
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.218
AC:
14824
AN:
67972
Other (OTH)
AF:
0.313
AC:
660
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1461
2922
4383
5844
7305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.247
Hom.:
10984
Bravo
AF:
0.330
Asia WGS
AF:
0.178
AC:
617
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
14
DANN
Benign
0.61
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6789961; hg19: chr3-189587091; COSMIC: COSV53195425; API